Table 2.

Predictive model for chemotherapy-associated VTE (62).

Patient characteristics	Risk score
Site of cancer
Very high risk (stomach, pancreas)	2
High risk (lung, lymphoma, gynecologic, bladder, testicular)	1
Prechemotherapy platelet count ≥350,000/μL	1
Hemoglobin <10 g/dl or use of RBC growth factors	1
Prechemotherapy leukocyte count >11,000/μL	1
Body mass index ≥35 kg/m2	1

High risk defined as risk score ≥3. VTE, venous thromboembolism.